Publications by authors named "Di Gregorio Eleonora"

Article Synopsis
  • The study investigates the use of genomic DNA methylation analysis, or episignature profiling, in diagnosing neurodevelopmental disorders (NDDs) by evaluating two cohorts of patients: one with known pathogenic variants and another with uncertain mutations.
  • In the validation group of 59 patients, 90% exhibited expected episignatures, although some variants displayed overlapping profiles due to similar clinical symptoms.
  • In the test cohort of 38 patients, five cases identified novel pathogenic variants and confirmed diagnoses for conditions such as Cornelia de Lange syndrome, highlighting the potential of episignature analysis to tackle complex genetic diagnosis challenges.
View Article and Find Full Text PDF
Article Synopsis
  • - ELOVL5, a protein in the endoplasmic reticulum, plays a crucial role in elongating long-chain fatty acids, and a specific mutation (p.G230V) in this protein is linked to Spinocerebellar Ataxia subtype 38 (SCA38), a neurodegenerative disorder.
  • - The study found that while ELOVL5 activity remains normal in the presence of the mutation, SCA38 patient-derived cells exhibited reduced ELOVL5 expression, enlarged Golgi complexes, and increased protein degradation compared to healthy controls.
  • - Structural analysis revealed that the mutation alters a critical intramolecular disulfide bond, suggesting that SCA38 involves both loss of function due to
View Article and Find Full Text PDF
Article Synopsis
  • The study identifies a new autosomal dominant disorder linked to loss-of-function variants in the CAPRIN1 gene, which plays a role in neuronal mRNA transport and translation, affecting cognitive and developmental functions.
  • Out of 12 cases studied, patients exhibited a range of neurodevelopmental issues, including language impairments, intellectual disabilities, ADHD, and autism, along with various physical health problems.
  • Using CRISPR-Cas9 technology, the researchers created CAPRIN1 deficient stem cells, finding that the loss of this gene leads to disrupted neuronal organization, reduced neuronal function, and impaired calcium signaling, suggesting significant impacts on brain development and function.
View Article and Find Full Text PDF
Article Synopsis
  • * Researchers analyzed clinical and genetic data from 36 individuals with CDH+ to identify genes that may influence diaphragm development and reveal new related health conditions.
  • * They found potential harmful variants in genes (CREBBP, SMARCA4, UBA2, USP9X) that are expressed in developing mouse diaphragms, suggesting these genes contribute to diaphragm development and furthering our understanding of CDH.
View Article and Find Full Text PDF
Article Synopsis
  • Elovl5 is an enzyme responsible for elongating 18-carbon fatty acids, which are crucial for maintaining the structure of myelin, the protective layer around nerves.
  • In studies involving Elovl5-deficient mice, researchers observed myelin structural changes and reduced sciatic nerve conduction velocity, indicating a potential defect in nerve signal transmission.
  • The lipid analysis showed an imbalance in fatty acid composition, highlighting Elovl5’s vital role in ensuring normal myelin structure and function in the peripheral nervous system.
View Article and Find Full Text PDF

The 22q11.2 microdeletion syndrome (22q11.2 DGS) is characterized by an extreme intrafamilial and interfamilial variability.

View Article and Find Full Text PDF

Fibroblast growth factor receptor-like 1 (FGFRL1) encodes a transmembrane protein that is related to fibroblast growth factor receptors but lacks an intercellular tyrosine kinase domain. in vitro studies suggest that FGFRL1 inhibits cell proliferation and promotes cell differentiation and cell adhesion. Mice that lack FGFRL1 die shortly after birth from respiratory distress and have abnormally thin diaphragms whose muscular hypoplasia allows the liver to protrude into the thoracic cavity.

View Article and Find Full Text PDF
Article Synopsis
  • - Short-term treatment with low doses of glucocorticoid analogues, like dexamethasone, can improve neurological symptoms in Ataxia-Telangiectasia (A-T), a rare disease affecting the brain and immune system.
  • - The study examined whether dexamethasone could induce an alternative ATM transcript (ATMdexa1) but found no evidence of this effect in A-T cell types or ATM-knockout cells.
  • - Researchers highlighted that some results linked to ATMdexa1 may be due to cellular artifacts, suggesting that caution is needed when interpreting the effects of dexamethasone in lab settings before applying it to A-T patient treatment.
View Article and Find Full Text PDF

Potocki-Shaffer syndrome (PSS) is a rare non-recurrent contiguous gene deletion syndrome involving chromosome 11p11.2. Current literature implies a minimal region with haploinsufficiency of three genes, (parietal foramina), (multiple exostoses), and (craniofacial anomalies, and intellectual disability).

View Article and Find Full Text PDF

Congenital sensorineural hearing loss may occur in association with inborn pigmentary defects of the iris, hair, and skin. These conditions, named auditory-pigmentary disorders (APDs), represent extremely heterogeneous hereditary diseases, including Waardenburg syndromes, oculocutaneous albinism, Tietz syndrome, and piebaldism. APDs are part of the neurocristopathies, a group of congenital multisystem disorders caused by an altered development of the neural crest cells, multipotent progenitors of a wide variety of different lineages, including those differentiating into peripheral nervous system glial cells and melanocytes.

View Article and Find Full Text PDF
Article Synopsis
  • Spinocerebellar Ataxia 38 (SCA38) is linked to a mutation in the ELOVL5 gene, leading to low levels of serum docosahexaenoic acid (DHA), but DHA supplementation has shown short-term benefits.* -
  • A 2-year study with nine SCA38 patients evaluated the long-term effects of daily 600 mg DHA, showing sustained improvement in clinical symptoms and increased cerebellar metabolism without any side effects.* -
  • The findings suggest that long-term DHA supplementation is a viable treatment option for individuals with SCA38.*
View Article and Find Full Text PDF
Article Synopsis
  • - Spinocerebellar ataxia 28 (SCA28) is a genetic neurodegenerative disorder linked to mutations in the AFG3L2 gene, impacting mitochondrial function, but its mechanisms and treatments remain poorly understood.
  • - A new knock-in mouse model expressing a specific patient-derived mutation (p.Met665Arg) demonstrated developmental normality but exhibited signs of cerebellar ataxia and altered electrophysiological activity in Purkinje cells.
  • - Investigations revealed mitochondrial dysfunction in mutant mice, including reduced energy production and altered morphology, suggesting that these mitochondrial changes might be crucial for understanding SCA28 and developing potential therapies.
View Article and Find Full Text PDF
Article Synopsis
  • Spinocerebellar ataxia (SCA) types 1, 2, 3, 6, and 7, caused by (CAG) repeat expansions, are the most common autosomal dominant ataxias, making up about 60% of cases globally.
  • The diagnosis typically involves PCR testing to find expanded alleles, but current methods can miss certain cases, prompting the need for improved techniques.
  • A new rapid and cost-effective diagnostic method has been developed that accurately identifies and sizes pathogenic expansions in SCA without needing follow-up tests, offering greater efficiency compared to traditional methods and next-generation sequencing.
View Article and Find Full Text PDF

Spino-Cerebellar-Ataxia type 38 (SCA38) is caused by missense mutations in the very long chain fatty acid elongase 5 gene, . The main clinical findings in this disease are ataxia, hyposmia and cerebellar atrophy. Mice in which has been knocked out represent a model of the loss of function hypothesis of SCA38.

View Article and Find Full Text PDF
Article Synopsis
  • Spinocerebellar ataxia 38 (SCA38) is linked to mutations in the ELOVL5 gene, leading to reduced levels of docosahexaenoic acid (DHA), a crucial fatty acid, which negatively impacts patients' health.* -
  • A study involving 10 SCA38 patients showed that after 16 weeks of DHA supplementation, clinical improvements were significantly greater compared to a placebo group, and continued benefits were observed after 40 weeks of treatment.* -
  • The research indicated that DHA is a safe and effective treatment for SCA38, resulting in improved clinical symptoms and brain function without any reported side effects.*
View Article and Find Full Text PDF

We report on a 58-year old woman with microcephaly, mild dysmorphic features, bilateral keratoconus, digital abnormalities, short stature and mild cognitive delay. Except for keratoconus, the phenotype was suggestive for Feingold syndrome type 2 (FGLDS2, MIM 614326), a rare autosomal dominant disorder described in six patients worldwide, due to the haploinsufficiency of MIR17HG, a micro RNA encoding gene. Karyotype showed a de novo deletion on chromosome 13q, further defined by array-Comparative Genomic Hybridization (a-CGH) to a 17.

View Article and Find Full Text PDF
Article Synopsis
  • Over 100 X-linked intellectual disability (X-LID) genes contribute to 10-15% of intellectual disabilities, prompting researchers to explore novel genetic candidates in affected families.
  • Using whole exome sequencing (WES), the study identified genetic variants in seven cases of undiagnosed X-LID, successfully diagnosing four cases, including overlooked syndromes like Coffin-Lowry and ATRX.
  • The findings suggest that WES can effectively unveil complex intellectual disability phenotypes linked to multiple genetic mutations, highlighting the importance of genetic testing in understanding rare conditions.
View Article and Find Full Text PDF

Introduction: SCA38 (MIM 611805) caused by mutations within the ELOVL5 gene, which encodes an enzyme involved in the synthesis of long-chain fatty acids with a high and specific expression in Purkinje cells, has recently been identified.

Objective: The present study was aimed at describing the clinical and neuroimaging features, and the natural history of SCA38.

Methods: We extended our clinical and brain neuroimaging data on SCA38 including 21 cases from three Italian families.

View Article and Find Full Text PDF

Whole exome sequencing (WES) is a powerful tool to identify clinically undefined forms of intellectual disability/developmental delay (ID/DD), especially in consanguineous families. Here we report the genetic definition of two sporadic cases, with syndromic ID/DD for whom array-Comparative Genomic Hybridization (aCGH) identified a de novo copy number variant (CNV) of uncertain significance. The phenotypes included microcephaly with brachycephaly and a distinctive facies in one proband, and hypotonia in the legs and mild ataxia in the other.

View Article and Find Full Text PDF

Karyotyping and aCGH are routinely used to identify genetic determinants of major congenital malformations (MCMs) in fetal deaths or terminations of pregnancy after prenatal diagnosis. Pathogenic rearrangements are found with a variable rate of 9-39% for aCGH. We collected 33 fetuses, 9 with a single MCM and 24 with MCMs involving 2-4 organ systems.

View Article and Find Full Text PDF

Copy number variation (CNV) has been associated with a variety of neuropsychiatric disorders, including intellectual disability/developmental delay (ID/DD), autism spectrum disorder (ASD), and schizophrenia (SCZ). Often, individuals carrying the same pathogenic CNV display high clinical variability. By array-CGH analysis, we identified a novel familial 3q29 deletion (1.

View Article and Find Full Text PDF